Cost-effectiveness of inhaled fluticasone propionate in the treatment of patients with chronic obstructive pulmonary disease (COPD)

被引：0
|
作者：
Hurrell, C [1 ]
Price, MJ [1 ]
Hollingworth, KE [1 ]
Thwaites, RMA [1 ]
机构：
[1] Glaxo Wellcome, Greenford, Middx, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：A797 / A797
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS ANALYSIS OF GLYCOPYRRONIUM BROMIDE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN
    Torres, C.
    Betoret, I
    Sabater, E.
    Figueras, M.
    Casado, M. A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A372 - A372
  • [42] Evaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease
    Naik, Shalini
    Kamal, Khalid M.
    Keys, Patricia A.
    Mattei, Thomas J.
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2010, 2 : 25 - 36
  • [43] A COST-EFFECTIVENESS ANALYSIS ON THE USE OF INDACATEROL FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEXICO
    Briones, B.
    Zuniga, G.
    Garcia-Contreras, F.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A139 - A139
  • [44] Cost effectiveness of inhaled steroid withdrawal in outpatients with chronic obstructive pulmonary disease
    van der Palen, J
    Monninkhof, E
    van der Valk, P
    Sullivan, SD
    Veenstra, DL
    [J]. THORAX, 2006, 61 (01) : 29 - 33
  • [45] Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis
    Job FM van Boven
    Eline Tommelein
    Koen Boussery
    Els Mehuys
    Stefan Vegter
    Guy GO Brusselle
    Maureen PMH Rutten-van Mölken
    Maarten J Postma
    [J]. Respiratory Research, 15
  • [46] Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis
    van Boven, Job F. M.
    Tommelein, Eline
    Boussery, Koen
    Mehuys, Els
    Vegter, Stefan
    Brusselle, Guy G. O.
    Rutten-van Molken, Maureen P. M. H.
    Postma, Maarten J.
    [J]. RESPIRATORY RESEARCH, 2014, 15
  • [47] Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma
    Doull, Lolo
    Price, David
    Thomas, Mike
    Hawkins, Neil
    Stamuli, Eugena
    Tabberer, Maggie
    Gosden, Toby
    Rudge, Helen
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 1147 - 1159
  • [48] Evaluating fluticasone furoate plus vilanterol for the treatment of chronic obstructive pulmonary disease (COPD)
    Lal, Chitra
    Strange, Charlie
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (09) : 1075 - 1085
  • [49] Inhaled Corticosteroid Treatment in Chronic Obstructive Pulmonary Disease (COPD): Boon or Bane?
    Kaplan, Alan G.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (02) : 289 - 302
  • [50] COMPARISON OF TWO ECONOMIC MODELS IN THE EVALUATION OF THE COST-EFFECTIVENESS OF TRIPLE THERAPY TREATMENT FOR ADVANCED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Baker, T. M.
    Martin, A.
    Abreu, C.
    Schroeder, M.
    Risebrough, N.
    Ismaila, A. S.
    [J]. VALUE IN HEALTH, 2019, 22 : S353 - S353
12345